Tetsuya Tsukamoto, Noriko Nakajima, Aki Sakurai, Masayuki Nakajima, Eiko Sakurai, Yuko Sato, Kenta Takahashi, Takayuki Kanno, Michiko Kataoka, Harutaka Katano, Mitsunaga Iwata, Yohei Doi, Tadaki Suzuki
Postmortem lung pathology of a patient in Japan with severe acute respiratory syndrome coronavirus 2 infection showed diffuse alveolar damage as well as bronchopneumonia caused by Streptococcus pneumoniae infection. The distribution of each pathogen and the accompanying histopathology suggested the infections progressed in a mutually exclusive manner within the lung, resulting in fatal respiratory failure.
January 14, 2021: Emerging Infectious Diseases
Fernando A Gouvea-Reis, Patrícia D Oliveira, Danniely C S Silva, Lairton S Borja, Jadher Percio, Fábio S Souza, Cássio Peterka, Claudia Feres, Janaína de Oliveira, Giselle Sodré, Wallace Dos Santos, Camile de Moraes
An outbreak of coronavirus disease began in a large penitentiary complex in Brazil on April 1, 2020. By June 12, there were 1,057 confirmed cases among inmates and staff. Nine patients were hospitalized, and 3 died. Mean serial interval was ≈2.5 days; reproduction number range was 1.0-2.3.
January 12, 2021: Emerging Infectious Diseases
Tara Swadi, Jemma L Geoghegan, Tom Devine, Caroline McElnay, Jillian Sherwood, Phil Shoemack, Xiaoyun Ren, Matt Storey, Sarah Jefferies, Erasmus Smit, James Hadfield, Aoife Kenny, Lauren Jelley, Andrew Sporle, Andrea McNeill, G Edwin Reynolds, Kip Mouldey, Lindsay Lowe, Gerard Sonder, Alexei J Drummond, Sue Huang, David Welch, Edward C Holmes, Nigel French, Colin R Simpson, Joep de Ligt
Since the first wave of coronavirus disease in March 2020, citizens and permanent residents returning to New Zealand have been required to undergo managed isolation and quarantine (MIQ) for 14 days and mandatory testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of October 20, 2020, of 62,698 arrivals, testing of persons in MIQ had identified 215 cases of SARS-CoV-2 infection. Among 86 passengers on a flight from Dubai, United Arab Emirates, that arrived in New Zealand on September 29, test results were positive for 7 persons in MIQ...
January 5, 2021: Emerging Infectious Diseases
Thomas Scheier, Adrian Schibli, Geri Eich, Christian Rüegg, Frank Kube, Adrian Schmid, Urs Karrer, Aline Wolfensberger, Hugo Sax, Peter W Schreiber
Switzerland began a national lockdown on March 16, 2020, in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We assessed the prevalence of SARS-CoV-2 infection among patients admitted to 4 hospitals in the canton of Zurich, Switzerland, in April 2020. These 4 acute care hospitals screened 2,807 patients, including 2,278 (81.2%) who did not have symptoms of coronavirus disease (COVID-19). Overall, 529 (18.8%) persons had >1 symptom of COVID-19, of whom 60 (11.3%) tested positive for SARS-CoV-2...
January 4, 2021: Emerging Infectious Diseases
Liselotte van Asten, Carel N Harmsen, Lenny Stoeldraijer, Don Klinkenberg, Anne C Teirlinck, Marit de Lange, Adam Meijer, Jan van de Kassteele, Arianne B van Gageldonk-Lafeber, Susan van den Hof, Wim van der Hoek
Since the 2009 influenza pandemic, the Netherlands has used a weekly death monitoring system to estimate deaths in excess of expectations. We present estimates of excess deaths during the ongoing coronavirus disease (COVID-19) epidemic and 10 previous influenza epidemics. Excess deaths per influenza epidemic averaged 4,000. The estimated 9,554 excess deaths (41% in excess) during the COVID-19 epidemic weeks 12-19 of 2020 appeared comparable to the 9,373 excess deaths (18%) during the severe influenza epidemic of 2017-18...
January 4, 2021: Emerging Infectious Diseases
Megan Wallace, Allison E James, Rachel Silver, Mitsuki Koh, Farrell A Tobolowsky, Sean Simonson, Jeremy A W Gold, Rena Fukunaga, Henry Njuguna, Keith Bordelon, Jonathan Wortham, Melissa Coughlin, Jennifer L Harcourt, Azaibi Tamin, Brett Whitaker, Natalie J Thornburg, Ying Tao, Krista Queen, Anna Uehara, Clinton R Paden, Jing Zhang, Suxiang Tong, Danielle Haydel, Ha Tran, Kaylee Kim, Kiva A Fisher, Mariel Marlow, Jacqueline E Tate, Reena H Doshi, Theresa Sokol, Kathryn G Curran
To assess transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a detention facility experiencing a coronavirus disease outbreak and evaluate testing strategies, we conducted a prospective cohort investigation in a facility in Louisiana, USA. We conducted SARS-CoV-2 testing for detained persons in 6 quarantined dormitories at various time points. Of 143 persons, 53 were positive at the initial test, and an additional 58 persons were positive at later time points (cumulative incidence 78%)...
January 4, 2021: Emerging Infectious Diseases
Emily K Vraga, Leticia Bode
Efforts to address misinformation on social media have special urgency with the emergence of coronavirus disease (COVID-19). In one effort, the World Health Organization (WHO) designed and publicized shareable infographics to debunk coronavirus myths. We used an experiment to test the efficacy of these infographics, depending on placement and source. We found that exposure to a corrective graphic on social media reduced misperceptions about the science of 1 false COVID-19 prevention strategy but did not affect misperceptions about prevention of COVID-19...
January 4, 2021: Emerging Infectious Diseases
Pyoeng Gyun Choe, Kye-Hyung Kim, Chang Kyung Kang, Hyeon Jeong Suh, EunKyo Kang, Sun Young Lee, Nam Joong Kim, Jongyoun Yi, Wan Beom Park, Myoung-Don Oh
Waning humoral immunity in coronavirus disease patients has raised concern over usefulness of serologic testing. We investigated antibody responses of 58 persons 8 months after asymptomatic or mildly symptomatic infection with severe acute respiratory syndrome coronavirus 2. For 3 of 4 immunoassays used, seropositivity rates were high (69.0%-91.4%).
December 22, 2020: Emerging Infectious Diseases
Maryam Shakiba, Maryam Nazemipour, Arsalan Salari, Fardin Mehrabian, Seyed Saeed H Nazari, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Mohammad Ali Mansournia
We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).
December 21, 2020: Emerging Infectious Diseases
Jefferson M Jones, Ian Kracalik, Meenakshi M Rana, Ann Nguyen, Brian C Keller, Aaron Mishkin, Charles Hoopes, Thomas Kaleekal, Abhinav Humar, Juan Vilaro, Gene Im, Lou Smith, April Justice, Collette Leaumont, Stephen Lindstrom, Brett Whitaker, Ricardo M La Hoz, Marian G Michaels, David Klassen, Wendi Kuhnert, Sridhar V Basavaraju
We conducted public health investigations of 8 organ transplant recipients who tested positive for severe acute respiratory syndrome coronavirus 2 infection. Findings suggest the most likely source of transmission was community or healthcare exposure, not the organ donor. Transplant centers should educate transplant candidates and recipients about infection prevention recommendations.
December 16, 2020: Emerging Infectious Diseases
Tomohiro Hosoda, Sohei Harada, Koh Okamoto, Sumire Ishino, Makoto Kaneko, Masahiro Suzuki, Ryota Ito, Miyuki Mizoguchi
A patient in Japan with coronavirus disease and hypervirulent Klebsiella pneumoniae K2 sequence type 86 infection died of respiratory failure. Bacterial and fungal co-infections caused by region-endemic pathogens, including hypervirulent K. pneumoniae in eastern Asia, should be included in the differential diagnosis of coronavirus disease patients with acutely deteriorating condition.
December 15, 2020: Emerging Infectious Diseases
Antonella Amendola, Silvia Bianchi, Maria Gori, Daniela Colzani, Marta Canuti, Elisa Borghi, Mario C Raviglione, Gian Vincenzo Zuccotti, Elisabetta Tanzi
We identified severe acute respiratory syndrome coronavirus 2 RNA in an oropharyngeal swab specimen collected from a child with suspected measles in early December 2019, ≈3 months before the first identified coronavirus disease case in Italy. This finding expands our knowledge on timing and mapping of novel coronavirus transmission pathways.
December 8, 2020: Emerging Infectious Diseases
Louis Wolff, Delphine Martiny, Véronique Yvette Miendje Deyi, Evelyne Maillart, Philippe Clevenbergh, Nicolas Dauby
We report 4 cases of Fusobacterium nucleatum bacteremia associated with coronavirus disease (COVID-19). Three cases occurred concomitantly with COVID-19 diagnosis; 1 occurred on day 15 of intensive care. None of the patients had known risk factors for F. nucleatum bacteremia. F. nucleatum infection could represent a possible complication of COVID-19.
December 8, 2020: Emerging Infectious Diseases
Nathaniel M Lewis, Lindsey M Duca, Perrine Marcenac, Elizabeth A Dietrich, Christopher J Gregory, Victoria L Fields, Michelle M Banks, Jared R Rispens, Aron Hall, Jennifer L Harcourt, Azaibi Tamin, Sarah Willardson, Tair Kiphibane, Kimberly Christensen, Angela C Dunn, Jacqueline E Tate, Scott Nabity, Almea M Matanock, Hannah L Kirking
Virus shedding in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur before onset of symptoms; less is known about symptom progression or infectiousness associated with initiation of viral shedding. We investigated household transmission in 5 households with daily specimen collection for 5 consecutive days starting a median of 4 days after symptom onset in index patients. Seven contacts across 2 households implementing no precautionary measures were infected. Of these 7, 2 tested positive for SARS-CoV-2 by reverse transcription PCR on day 3 of 5...
December 4, 2020: Emerging Infectious Diseases
Camilla Rothe, Thorbjörn Zimmer, Mirjam Schunk, Claudia Wallrauch, Kerstin Helfrich, Fatih Gültekin, Gisela Bretzel, Jean-François Allienne, Jérôme Boissier
Urogenital schistosomiasis was diagnosed in a man from Germany who had never traveled outside Europe. He likely acquired the infection in Corsica, France, but did not swim in the Cavu River, which was linked to a previous outbreak. This case highlights that transmission of schistosomiasis in Corsica is ongoing.
December 2, 2020: Emerging Infectious Diseases
Adrian Trenholme, Rachel Webb, Shirley Lawrence, Sharon Arrol, Susan Taylor, Shanthi Ameratunga, Catherine A Byrnes
In March 2020, a national elimination strategy for coronavirus disease was introduced in New Zealand. Since then, hospitalizations for lower respiratory tract infection among infants <2 years of age and cases of respiratory syncytial or influenza virus infection have dramatically decreased. These findings indicate additional benefits of coronavirus disease control strategies.
December 2, 2020: Emerging Infectious Diseases
Nadine Muller, Mareike Kunze, Fabienne Steitz, Neil J Saad, Barbara Mühlemann, Jörn I Beheim-Schwarzbach, Julia Schneider, Christian Drosten, Lukas Murajda, Sandra Kochs, Claudia Ruscher, Jan Walter, Nadine Zeitlmann, Victor M Corman
We report an outbreak of coronavirus disease with 74 cases related to a nightclub in Germany in March 2020. Staff members were particularly affected (attack rate 56%) and likely caused sustained viral transmission after an event at the club. This outbreak illustrates the potential for superspreader events and corroborates current club closures.
December 2, 2020: Emerging Infectious Diseases
Isaac H Solomon, Vijay S Ganesh, Guixia Yu, Xian Ding Deng, Michael R Wilson, Steve Miller, Tracey A Milligan, Shibani S Mukerji, Abigail Mathewson, Justin Linxweiler, Darlene Morse, Jana M Ritter, J Erin Staples, Holly Hughes, Carolyn V Gould, Pardis C Sabeti, Charles Y Chiu, Anne Piantadosi
A 56-year-old man receiving rituximab who had months of neurologic symptoms was found to have Jamestown Canyon virus in cerebrospinal fluid by clinical metagenomic sequencing. The patient died, and postmortem examination revealed extensive neuropathologic abnormalities. Deep sequencing enabled detailed characterization of viral genomes from the cerebrospinal fluid, cerebellum, and cerebral cortex.
December 1, 2020: Emerging Infectious Diseases
Shu-Chen Kuo, Hsiao-Hui Tsou, Hsiao-Yu Wu, Ya-Ting Hsu, Fang-Jing Lee, Shu-Man Shih, Chao A Hsiung, Wei J Chen
In Taiwan, lower nonpolio enterovirus activity during the coronavirus disease pandemic in 2020 compared with 2014-2019 might be attributable to adherence to nonpharmaceutical interventions. The preventable fraction among unexposed persons indicated that 90% of nonpolio enterovirus activity might have been prevented during 2014-2019 by adopting the same measures enforced in 2020.
December 1, 2020: Emerging Infectious Diseases
Floriane Gallais, Aurélie Velay, Charlotte Nazon, Marie-Josée Wendling, Marialuisa Partisani, Jean Sibilia, Sophie Candon, Samira Fafi-Kremer
We investigated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies and T-cell responses against SARS-CoV-2 and human coronavirus (HCoV) 229E and OC43 in 11 SARS-CoV-2 serodiscordant couples in Strausbourg, France, in which 1 partner had evidence of mild coronavirus disease (COVID-19) and in 10 unexposed healthy controls. Patients with confirmed COVID-19 were considered index patients and their partners close contacts. All index patients displayed positive SARS-CoV-2-specific antibody and T-cell responses that lasted up to 102 days after symptom onset...
December 1, 2020: Emerging Infectious Diseases
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"